Exploring Speech and Language Therapists' Perspectives of Voice-Assisted Technology as a Tool for Dysarthria: Qualitative Study.
Jodie Mills, Orla Duffy, Katy Pedlow and 1 others
PMID 40896823WHAT IT FOUND
Seven UK speech therapists found smart speakers useful for home practice because the devices give objective feedback without judgment.
However, they reported clients became frustrated when the technology failed to understand their speech or timed out during exercises.
Key findings
01Therapists used smart speakers to provide objective, unjudgmental feedback on volume and clarity, which encouraged clients to adapt their speech and reduced reluctance to speak out.
02Clients frequently experienced frustration when devices failed to recognize intelligible speech, timed out, or provided poor error scaffolding, which impacted confidence.
03Therapists identified significant barriers to implementation, including gaps in their own technical knowledge, privacy and GDPR concerns, and the inability to monitor home use.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Small sample size (7 participants) limits generalizability. Participants were already users of the technology, likely leading to positive selection bias and underrepresenting barriers faced by non-users. Study focused on UK therapists, so findings may not apply to other healthcare systems or cultural contexts. No data was collected on the severity of dysarthria of the clients treated, so applicability to severe cases is unknown.
Declared interests
None declared.
The easy way to misread this
Do not interpret the therapists' positive reports on 'improved volume' as evidence of clinical efficacy. These were subjective perceptions from a small group of enthusiastic users, not objective acoustic measurements, and the study did not compare outcomes against a control group or standard therapy.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →